During the past decade, Sumida Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 4 clinical trials were completed, i.e. on average, 19% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 3 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sumida Hospital" #1 sponsor was "Takeda" with 6 trials, followed by "Janssen Pharmaceutical K.K." with 5 trials sponsored, "Pfizer" with 3 trials sponsored, "Bayer" with 2 trials sponsored and "BioNTech SE" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sumida Hospital" #1 collaborator was "Janssen Research & Development, LLC" with 3 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Sumida Hospital" are "Healthy" (4 trials), "Clinical Pharmacology" (2 trials), "Coronavirus Disease (COVID-19)" (2 trials), "COVID-19" (1 trials) and "Clostridium Difficile Associated Disease" (1 trials). Many other conditions were trialed in "Sumida Hospital" in a lesser frequency.

Most popular intervention types in "Sumida Hospital" are "Drug" (13 trials), "Biological" (7 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "TAK-925" (3 trials), "Rivaroxaban (BAY 59-7939, Xarelto) in ODT form" (2 trials), "Rivaroxaban (BAY 59-7939, Xarelto) in film-coated form" (2 trials) and "TAK-019" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sumida Hospital" are 15 trials for "All" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Sumida Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Sumida Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sumida Hospital, 14 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".